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Abstract
Statistical process control (SPC) charts may be used to detect acute variations in the data while 
simultaneously evaluating unforeseen aberrations that may warrant further investigation by the 
data user. Using cancer stage data captured by the Summary Stage 2000 (SS2000) variable, we 
sought to present a brief report highlighting the utility of the SPC chart during the quality 
assessment of cancer registry data. Using a county-level caseload for the diagnosis period of 
2001–2004 (n=25,648), we found the overall variation of the SS2000 variable to be in control 
during diagnosis years of 2001 and 2002, exceeded the lower control limit (LCL) in 2003, and 
exceeded the upper control limit (UCL) in 2004; in situ/localized stages were in control 
throughout the diagnosis period, regional stage exceeded UCL in 2004, and distant stage exceeded 
the LCL in 2001 and the UCL in 2004. Our application of the SPC chart with cancer registry data 
illustrates that the SPC chart may serve as a readily available and timely tool for identifying areas 
of concern during the data collection and quality assessment of central cancer registry data.
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Introduction
Historically, the quality assurance of cancer registry data has relied on the interpretation of 
counts, proportions and/or rates for the identification of irregularities within data 
collected.1–3 However, frequent quality control analyses using these methods with cancer 
registry data may be impractical and can show statistically significant but not clinically 
relevant changes in data. To maintain the high quality of data that are collected, 
consolidated, and edited by cancer registrars at the central cancer registry, methods—such as 
a statistical process control (SPC) chart— that use quantifiable numeric indicators to readily 
detect and identify variations in registry data may be more preferable to descriptive analyses 
that are often subjective and qualitative.
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Originally created as an industrial tool for measuring the performance of routine 
manufacturing processes, the SPC chart’s strength is that it allows the data user to draw 
logical decisions, rather than sudden judgments based on “last month” regarding the need 
for investigation, change in procedures, etc.4 The underlying principle of a SPC chart is that 
all processes vary inherently and the end result can be described in statistical terms. The 
assumption of a SPC chart is that if the occurrence of a particular event is examined over 
time, the number of events in a set period of time (eg, 1 month) will follow a statistical 
distribution generally approximating a bell-shaped curve.4 If the distribution of the 
occurrence over time is consistent, then the occurrences in the current time period will be 
statistically consistent with the historical experience of the event. In regards to the 
assessment of cancer registry data, a SPC chart has the capacity to identify changes in the 
reporting of data elements, while discriminating when and where during the data collection 
the change had occurred and prompt the registry’s quality assurance staff to investigate the 
issue further.
Structurally, SPC charts are chronological graphs of data with control limits (typically set at 
2 or 3 standard deviations from the expected value) represented by horizontal lines on the 
graph (see sample chart in Figure 1). These lines, encompassing the center line (CL) 
(usually the mean of the statistic of interest), upper control limit (UCL) and the lower 
control limit (LCL), define the central tendency and range of natural variation of plotted 
values assuming that change within the data will not occur without being due to chance. 
Values plotted outside the UCL and LCL are considered to be statistically significant 
indications that a process is not producing outcomes from one consistent and homogenous 
process, while values plotted within these limits are considered to be a result of natural 
variation and “in control.”
As iterated earlier, the SPC chart may be used to detect acute variations in the data while 
simultaneously evaluating unforeseen aberrations that may warrant further investigation by 
the data user. In this current example, we will present a brief report highlighting the utility 
of the SPC chart during the quality assessment of cancer registry data using the Summary 
Stage 2000 (SS2000) variable as collected by Centers for Disease Control and Prevention’s 
National Program of Cancer Registries (CDC-NPCR). Considering the well-documented 
change in the reporting of cancer stage by central cancer registries (CCRs) from 1998–2004, 
we believe the analysis of the SS2000 variable provides an opportunity to present the 
strengths of the SPC chart using a period of time where known changes in data collection 
had occurred and were due to factors outside of the statistical realm of chance. Since 1996, 
changes in the reporting to the SS variable have included: (1) cancer staging based on direct 
codes from Summary Stage 1977, (2) cancer staging based on direct codes from SS2000, 
and (3) the implementation of collaborative staging (deriving stage based upon TNM staging 
and SEER SS) that began in diagnosis year 2004. If effective, the SPC chart should detect 
the implementation of these changes and produce plots outside the LCL or UCL for 
diagnosis years occurring prior to 2001 and during the diagnosis year 2004.
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Data for the SS2000 variable were collected from 46 population-based cancer registries 
participating in the CDC-NPCR. The CDC-NPCR data used were submitted in the NPCR-
CSS Call for Data and reported to CDC as of January 31, 2009. These registries met 
established criteria for high-quality data. Information on states that met established data 
quality criteria for United States Cancer Statistics (USCS) is available at the CDC-NPCR’s 
website, http://www.cdc.gov/cancer/npcr/uscs/data/00_data_quality.html.
In testing our null hypothesis, we created an analytic dataset consisting of all cancer 
diagnoses from 1 US county (n=25,648) during the years of 1998–2004. Using a local 
registry-level caseload allowed us a true assessment of the utility of the SPC chart during a 
real-life scenario—in an ideal setting, an SPC chart will be performed by staff at the local or 
central cancer registries at the time of data collection and that will ensure potential 
irregularities in data have been assessed prior to the data submission.
Using the proc shewart function packaged with SASv9.2 statistical software (SAS Institute 
Inc., Cary, North Carolina) we then plotted the SS2000 variable (for each reported 
diagnosis) against the year of diagnosis on a SPC chart for 2 separate diagnosis periods 
including 1998–2004 and 2001–2004 with the alpha (α) for each chart equaling 0.01. We 
repeated this step to create stage-specific SPC charts for stages in situ/localized, regional 
and distant for both diagnosis periods. The comparison of 2 separate diagnosis periods 
allowed us to determine the SPC chart’s ability to detect changes in the cancer registry data 
using known time parameters where reporting practices had discretely changed over time.
Results
For the diagnosis period of 1998–2004, the overall variation (reflecting registry reports of in 
situ, localized, regional, distant, “blank(s)” and unstaged) of the SS2000 variable was never 
within the control limits (Figures 2a, 2b, 2c, and 2d, respectively). During this diagnosis 
period, stage-specific SPC charts presented plots for each cancer stage (in situ/localized, 
regional, and distant) consistently beyond the UCL following the diagnosis year of 2000. In 
comparison, during the diagnosis period of 2001–2004, we found the overall variation of the 
SS2000 variable to be in control during diagnosis years of 2001 and 2002, (unexpectedly) 
exceeded the LCL in 2003, and exceeded the UCL in 2004 (Figure 3a). Stage-specific charts 
found the staging of in situ/localized to be the only SS category to be in control throughout 
the diagnosis years of 2001–2004 (Figure 3b). During this same diagnosis period, the 
staging of regional exceeded UCL in 2004 (Figure 3c), while the staging of distant exceeded 
the LCL in 2001 and the UCL in 2004 (Figure 3d).
Discussion
Using the SPC chart here, we identified variation in CDC-NPCR data using a scenario in 
which we knew changes in data collection had occurred and were due to factors outside of 
the statistical realm of chance. Our example illustrated that the SPC chart may serve as an 
invaluable tool for prospectively identifying areas of concern during the data collection and 
quality assessment of cancer registry data. However, the generalizability of our charts is 
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challenged because of our consolidation of stage data from diagnoses of all cancer sites. For 
real-time application of the SPC chart, site-specific charts may be more appropriate to 
control for site-specific factors affecting cancer staging. German et al5 found the data quality 
analysis from the Patterns of Care Study (POC1) underscores the importance of examining 
the quality of specific data elements by cancer site.5 Further validation for the use of the 
SPC chart with cancer registry data should incorporate varying caseloads (ie state, regional 
and/or national levels) and utilize additional registry data elements beyond variables 
associated with cancer staging. Nonetheless, SPC charts presented here displayed their 
usefulness in identifying changes in cancer stage reporting, and potential for being a tool 
used during the ongoing monitoring of cancer registry data.
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Sample Statistical Process Control (SPC) Chart
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a. Statistical Process Control Chart Indicating Variation in Summary Stage 2000 Variable, 
Diagnosis Years 1998–2004
b. Statistical Process Control Chart Indicating Variation in Summary Stage 2000 Variable 
Reported as In Situ/Localized, Diagnosis Years 1998–2004
c. Statistical Process Control Chart Indicating Variation in Summary Stage 2000 Variable 
Reported as Regional, Diagnosis Years 1998–2004
d. Statistical Process Control Chart Indicating Variation in Summary Stage 2000 Variable 
Reported as Distant, Diagnosis Years 1998–2004
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a. Statistical Process Control Chart Indicating Variation in Summary Stage 2000 Variable, 
Diagnosis Years 2001–2004
b. Statistical Process Control Chart Indicating Variation in Summary Stage 2000 Variable 
Reported as In Situ/Localized, Diagnosis Years 2001–2004
c. Statistical Process Control Chart Indicating Variation in Summary Stage 2000 Variable 
Reported as Regional, Diagnosis Years 2001–2004
d. Statistical Process Control Chart Indicating Variation in Summary
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